4//SEC Filing
Seimetz Diane 4
Accession 0001818382-22-000087
CIK 0001818382other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:18 PM ET
Size
5.3 KB
Accession
0001818382-22-000087
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Seimetz Diane
Director
Transactions
- Award
Stock Options (right to buy)
2022-06-09+13,000→ 13,000 totalExercise: $4.34Exp: 2032-06-09→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001930980
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:18 PM ET
- Size
- 5.3 KB